In SLE, dexamethasone liposome-integrated mesenchymal stem cells (Dexlip-MSCs) activate GR signaling to upregulate cysteine-rich secretory protein LCCL-containing domain 2 (CRISPLD2) and suppress inflammatory mediators.729. The gene discussed is CRISPLD2; the disease is systemic lupus erythematosus.